Combined modality of 2-formylpyridine monothiosemicarbazonato copper(II) and radiation.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle; D002470:Cell Survival; D002478:Cells, Cultured; D002588:Cesium Radioisotopes; D003300:Copper / Q000494:pharmacology*; D006224:Cricetinae; D003412:Cricetulus; D004260:DNA Repair; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D011725:Pyridines / Q000494:pharmacology*; D013882:Thiosemicarbazones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D002588:Cesium Radioisotopes; D011725:Pyridines; D013882:Thiosemicarbazones; C013996:2-formylpyridine thiosemicarbazone; D003300:Copper